IPOPLUS

425.15

-7.25 -1.68%

18 Jun 2026

NSE Listed · Pharmaceuticals

Cohance Lifesciences Ltd. (COHANCE)

Volume: 20,370Avg Vol 1W: 1,58,952Avg Vol 1M: 4,03,36452W Range:266.71,121.15
₹425.15 1.68%
Market Cap₹16,328 Cr
Current Price₹425.15
Previous Close₹432.4
High / Low (52w)₹1,121.15 / ₹266.7
Volume20,370
Avg Vol (1W)1,58,952
Avg Vol (1M)4,03,364
Stock P/E110.25
Book Value₹102.23
Dividend Yield0%
ROE5.05%
ROA2.62%
Revenue (TTM)
Revenue Growth13.91%
Profit Margin7.9%
Total Debt₹6 Cr
Shares Outstanding38 Cr
Face Value₹1
EPS (TTM)₹0.51
P/B4.69
Debt / Equity0.1
50 DMA₹432.64
200 DMA₹372.27
Day change-1.68%
Price Chart
425.15 52.68% · 1Y
9612804.8Cr
2025-10-21
2026-06-16

20-day avg volume: 4.0L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 13% YoY.
Cons
  • Stock trades at a high P/E of 110.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹619 Cr₹545 Cr₹556 Cr₹549 Cr₹840 Cr₹676 Cr₹604 Cr₹488 Cr₹253 Cr₹220 Cr₹231 Cr₹348 Cr₹369 Cr₹354 Cr₹278 Cr₹339 Cr₹364 Cr₹392 Cr₹301 Cr₹264 Cr₹259 Cr₹275 Cr₹237 Cr₹238 Cr₹185 Cr
EBITDA₹46 Cr₹55 Cr₹93 Cr₹81 Cr₹187 Cr₹215 Cr₹184 Cr₹113 Cr₹73 Cr₹68 Cr₹106 Cr₹165 Cr₹171 Cr₹147 Cr₹99 Cr₹150 Cr₹163 Cr₹240 Cr₹118 Cr₹111 Cr₹89 Cr₹133 Cr₹91 Cr₹111 Cr₹75 Cr
Net Profit₹20 Cr₹37 Cr₹74 Cr₹49 Cr₹120 Cr₹153 Cr₹138 Cr₹75 Cr₹53 Cr₹47 Cr₹80 Cr₹121 Cr₹124 Cr₹108 Cr₹72 Cr₹108 Cr₹92 Cr₹160 Cr₹97 Cr₹105 Cr₹83 Cr₹114 Cr₹74 Cr₹92 Cr₹74 Cr
EPS0.50.961.931.273.14.013.611.972.11.843.134.744.874.232.834.223.66.293.814.133.274.462.913.65.83
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,256 Cr₹1,113 Cr₹1,387 Cr₹1,413 Cr₹1,024 Cr₹852 Cr
EBITDA₹356 Cr₹413 Cr₹565 Cr₹633 Cr₹423 Cr₹376 Cr
Net Profit₹268 Cr₹300 Cr₹411 Cr₹454 Cr₹362 Cr₹317 Cr
EPS10.4511.816.1617.8314.2312.45
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹3,032 Cr₹2,254 Cr₹1,966 Cr₹1,830 Cr₹1,474 Cr₹1,173 Cr
Total Liabilities₹1,191 Cr₹203 Cr₹231 Cr₹302 Cr₹294 Cr₹328 Cr
Equity₹1,841 Cr₹2,051 Cr₹1,735 Cr₹1,527 Cr₹1,181 Cr₹845 Cr
Total Debt₹6 Cr₹0 Cr₹5 Cr₹28 Cr₹36 Cr₹91 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹372 Cr₹468 Cr₹603 Cr₹514 Cr₹492 Cr₹493 Cr
Investing₹-255 Cr₹-362 Cr₹-195 Cr₹-136 Cr₹-311 Cr₹-413 Cr
Financing₹3 Cr₹-14 Cr₹-242 Cr₹-156 Cr₹-76 Cr₹7 Cr
Free Cash Flow₹372 Cr₹468 Cr₹603 Cr₹514 Cr₹492 Cr₹493 Cr
Shareholding
Promoter 57.49% Institutions 27.38% Public 15.12%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search